CytoSorbents Announces 1:20 Reverse Stock Split
CytoSorbents (CTSO) has announced plans to execute a one-for-twenty reverse stock split, effective on September 8, 2026. The move is intended to increase the per-share trading price of its common stock in order to meet Nasdaq's $1.00 minimum bid requirement. This action reflects efforts by CytoSorbents to maintain compliance with exchange listing standards and potentially improve investor perception through a higher share price, despite reducing the total number of outstanding shares significantly.
Topics: nasdaq compliance stock split